Tokyo, Japan

Taiichi Sirogane

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Taiichi Sirogane: Innovator in Therapeutic Solutions

Introduction

Taiichi Sirogane is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medical therapeutics, particularly in the treatment of disc herniation. With a total of 4 patents to his name, Sirogane's work is characterized by its innovative approach and focus on patient safety.

Latest Patents

One of Sirogane's latest patents is a therapeutic agent for disc herniation. This invention is notable for having extremely few adverse side effects. It can achieve a prolonged pain-ameliorating effect when administered in a single dose. The therapeutic agent is characterized by containing chondroitinase ABC as an active ingredient. It is designed to be administered into a human disk in an amount of 1-8 units per disk, ensuring high therapeutic effect and safety in clinical applications.

Career Highlights

Sirogane is associated with Seikagaku Corporation, a company known for its focus on innovative medical solutions. His work at the company has allowed him to explore and develop groundbreaking therapeutic agents that address significant medical challenges.

Collaborations

Some of his notable coworkers include Takao Murayama and Masafumi Yaguchi. Their collaboration has contributed to the advancement of research and development in the field of therapeutics.

Conclusion

Taiichi Sirogane's contributions to the field of medical therapeutics, particularly through his innovative patents, highlight his commitment to improving patient care. His work continues to pave the way for advancements in treatment options for disc herniation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…